𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Optimal vaccine scheduling in cancer immunotherapy

✍ Scribed by B. Piccoli; F. Castiglione


Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
375 KB
Volume
370
Category
Article
ISSN
0378-4371

No coin nor oath required. For personal study only.

✦ Synopsis


Cancer immunotherapy aims at stimulating the immune system to react against cancer stealth capabilities. It consists of repeatedly injecting small doses of a tumor-associated molecule one wants the immune system to recognize, until a consistent immune response directed against the tumor cells is observed.

We have applied the theory of optimal control to the problem of finding the optimal schedule of injections of an immunotherapeutic agent against cancer. The method employed works for a general ODE system and can be applied to find the optimal protocol in a variety of clinical problems where the kinetics of the drug or treatment and its influence on the normal physiologic functions have been described by a mathematical model.

We show that the choice of the cost function has dramatic effects on the kind of solution the optimization algorithm is able to find. This provides evidence that a careful ODE model and optimization schema must be designed by mathematicians and clinicians using their proper different perspectives.


πŸ“œ SIMILAR VOLUMES


Antigen-specific immunotherapy and cance
✍ Elke JΓ€ger; Dirk JΓ€ger; Alexander Knuth πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 70 KB

The specific activation of the immune system to control cancer growth in vivo has been a long-standing goal in cancer immunology and medical oncology. The identification of tumor-associated antigens has provided the basis for new concepts in antigen-specific immunotherapy. The first clinical trials

Optimizing cancer immunotherapy trials:
✍ Freda K Stevenson; Jason Rice πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 104 KB

## Abstract Attempts to raise effective immunity against cancer are benefiting from information on the nature of the immunity involved and its regulation and, perhaps, now it is time to step back and define our approach in molecular terms prior to clinical testing. Although there are immunological

Optimal control drug scheduling of cance
✍ R.B. Martin πŸ“‚ Article πŸ“… 1992 πŸ› Elsevier Science 🌐 English βš– 892 KB

Analytical gradients of all constraints are constructed and the problem solved numerically. The optimal treatment is low intensity therapy followed by high intensity therapy.